Back to trials
completed
Phase 2

NCT00165568

Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-tumoral Pharmacokinetics of 5-fluorouracil in Metastatic Colorectal Cancer

Sponsored by Dana-Farber Cancer Institute

Why you can trust this information
Registry sourcesNot yet reconciled
Source last updatedNot reported
Clintriva indexed9/27/2026, 9:27:53 PM
Registry records0
Relationships needing review0

Identity-resolution confidence concerns registry/entity resolution and does not determine clinical eligibility.

Interested in this trial?

Express your interest and we'll connect you with the trial team.

Your selected profile and contact information may be shared with an authorised trial site, sponsor, or Clintriva coordination team for trial contact and pre-screening. Expressing interest does not mean you are eligible or enrolled.

Quick Facts
Start DateJul 1, 2005
Completion—
Enrollment0/20
CountryUnited States

Conditions

Colorectal Cancer
Neoplasm Metastasis
View on registry
Clintriva
GDPR Controls Mapped HIPAA Safeguards Mapped NHS DSP Controls Mapped SOC 2 Controls Mapped

© 2026 Clintriva. All rights reserved.